The Reality of Most Checkpoint Inhibitors Being Copycat Drugs of Keytruda
Executive Summary The problem with the vast majority of checkpoint inhibitors being copycat drugs of Keytruda is that patients must deal with the highly problematic side effects of Keytruda regardless of the checkpoint inhibitor. Introduction This article covers the copycat drugs that are based on Keytruda. Wait One Second… Why is The Article Not Viewable?…